Researchers, clinicians, patient organisations and other stakeholders interested in rare disease clinical trials are invited to attend ERDERA’s Clinical Trial Call 2026 (ECTC) information webinar on 6 July 2026 from 15:00–17:00 CEST.

The webinar will provide an overview of the upcoming ERDERA Clinical Trial Call 2026, which opens on 1 July 2026 and will support multinational, GCP-compliant Phase I, Phase I/II and Phase II interventional clinical trials in rare diseases.

The call aims to generate robust clinical evidence and support the development of new therapies for rare diseases, particularly where patient populations are small and international collaboration is essential.

Applications will follow a multi-stage process, beginning with a mandatory Expression of Interest (EOI) phase running from 1 July to 10 September 2026, followed by the Short Proposal stage from 15 September to 29 October 2026.

The call is open to multinational consortia involving research institutions, hospitals, patient organisations and other eligible partners across at least three countries.

Further information, including the pre-announcement and draft call documents, is available through ERDERA. Please note that these documents are for information purposes only and may be subject to change before the official launch.